ASC Ownership: The Orthopedic Wealth Lever

An ambulatory surgery center (ASC) is a facility where outpatient procedures are performed — for orthopedic surgeons, this typically means arthroscopy, sports medicine procedures, carpal tunnel releases, same-day joint replacement in some cases. ASCs are usually structured as partnerships owned by the surgeons who operate there. Surgeon-owner ASCs produce distributions that often rival or exceed the surgeon's clinical comp.

How the economics work

A well-run orthopedic ASC with 8-12 surgeon-owners might see:

• $15-30M annual facility revenue
• EBITDA margins of 25-40% (high; ASCs have structural advantages over hospital-based surgery)
• $4-10M annual distributions to surgeon-owners
• $300K-$1M per surgeon per year (depending on ownership % and case volume contribution)

The distributions are separate from your clinical collections. You operate at the ASC, bill for your professional fee through your practice (clinical income), AND receive ASC distributions as an owner (facility income). Both streams matter.

Typical buy-in structure

• Buy-in cost: $200-400K for a new partner slot at an established ASC. Reflects a percentage of the facility's enterprise value.
• Payback: Distributions typically cover the buy-in in 2-4 years at a healthy facility. After that, it's positive cash flow.
• Financing: Most ASCs allow financed buy-ins with promissory notes. Typical terms: 5-7 years, 6-8% interest.
• Legal structure: Limited partnership or LLC. Tax treatment: K-1 partnership distributions.

How distributions are calculated

Two main models exist:

• Pro-rata by ownership percentage. If you own 10% of the ASC, you get 10% of distributions regardless of how many cases you personally bring. Common but creates free-rider dynamics.
• Production-weighted. Distributions weighted by each surgeon's case contribution to the facility. Fairer but more complex; Stark/Anti-Kickback considerations require careful structuring.

Most modern orthopedic ASCs use hybrid models — a base pro-rata share plus a production adjustment — designed specifically to comply with Anti-Kickback safe harbors.

Exit: selling the ASC

At some point, ASC owners often face a corporate acquisition offer. Major buyers:

• USPI (United Surgical Partners International — Tenet subsidiary)
• SurgCenter Development
• AmSurg / Envision
• Surgery Partners
• Regional players

Typical multiples: 6-10× EBITDA for the facility. For a $4M-distribution ASC, that's $24-40M enterprise value, or $2-4M per surgeon at 8-12 owners.

Deal structures commonly include: cash at close (60-75% of consideration), equity rollover into parent (20-30%), continued operator agreement (you keep practicing there, at a reduced facility fee because the acquirer now owns the facility).

Common mistakes

• Refusing the buy-in because it "feels expensive." $300K feels big, but distributions typically pay it back in 3 years. Missing the opportunity costs millions over a career.
• Buying in without modeling case-contribution fit. If you don't generate enough case volume to justify your share, pro-rata distribution math can make you a net contributor rather than beneficiary.
• Ignoring Stark/Anti-Kickback structure. An ASC arrangement that pays you more because you bring more cases is potentially a kickback. Must be structured within safe harbors.
• Over-concentrating. ASC + practice partnership + clinical income all tied to the same surgical market. One regulatory change or local market shift hits everything.